Engineered Human Cardiac Tissue from Skeletal Muscle Derived Cells and Induced Pluripotent Stem Cell Derived Cardiomyocytes

被引：0
|
作者：
Tobita, Kimimasa [1 ]
Tchao, Jason S. [1 ]
Kim, Jong [1 ]
Lin, Bo [1 ]
Huard, Johnny [1 ]
Salama, Guy [1 ]
Yang, Lei [1 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
来源：
CIRCULATION RESEARCH | 2012年 / 111卷 / 04期
关键词：
Regenerative medicine stem cells; Cardiac development; Tissue engineering;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
366
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Cardiomyocytes derived from human induced pluripotent stem cells as models for normal and diseased cardiac electrophysiology and contractility
    Blazeski, Adriana
    Zhu, Renjun
    Hunter, David W.
    Weinberg, Seth H.
    Zambidis, Elias T.
    Tung, Leslie
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2012, 110 (2-3): : 166 - 177
  • [42] Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells
    Li, Jiangtao
    Feng, Xin
    Wei, Xiang
    STEM CELL RESEARCH & THERAPY, 2022, 13 (01)
  • [43] The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells
    Yokoo, Noritaka
    Baba, Shiro
    Kaichi, Shinji
    Niwa, Akira
    Mima, Takahiro
    Doi, Hiraku
    Yamanaka, Shinya
    Nakahata, Tatsutoshi
    Heike, Toshio
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 387 (03) : 482 - 488
  • [44] Doxorubicin-induced toxicity in cardiomyocytes derived from human pluripotent stem cells
    Holmgren, Gustav
    Synnergren, Jane
    Bogestal, Yalda
    Ameen, Caroline
    Akesson, Karolina
    Holmgren, Sandra
    Lindahl, Anders
    Sartipy, Peter
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2015, 75 : 195 - 195
  • [45] Modelling sarcomeric cardiomyopathies with human cardiomyocytes derived from induced pluripotent stem cells
    Sewanan, Lorenzo R.
    Campbell, Stuart G.
    JOURNAL OF PHYSIOLOGY-LONDON, 2020, 598 (14): : 2909 - 2922
  • [46] Cardiac Toxicity From Ethanol Exposure in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Rampoldi, Antonio
    Singh, Monalisa
    Wu, Qingling
    Duan, Meixue
    Jha, Rajneesh
    Maxwell, Joshua T.
    Bradner, Joshua M.
    Zhang, Xiaoyu
    Saraf, Anita
    Miller, Gary W.
    Gibson, Greg
    Brown, Lou Ann
    Xu, Chunhui
    TOXICOLOGICAL SCIENCES, 2019, 169 (01) : 280 - 292
  • [47] Pivotal Role of Non-cardiomyocytes in Electromechanical and Therapeutic Potential of Induced Pluripotent Stem Cell-Derived Engineered Cardiac Tissue
    Iseoka, Hiroko
    Miyagawa, Shigeru
    Fukushima, Satsuki
    Saito, Atsuhiro
    Masuda, Shigeo
    Yajima, Shin
    Ito, Emiko
    Sougawa, Nagako
    Takeda, Maki
    Harada, Akima
    Lee, Jong-Kook
    Sawa, Yoshiki
    TISSUE ENGINEERING PART A, 2018, 24 (3-4) : 287 - 300
  • [48] Cardiac toxicity from bisphenol A exposure in human-induced pluripotent stem cell-derived cardiomyocytes
    Hyun, Sung-Ae
    Lee, Chang Youn
    Ko, Moon Yi
    Chon, Sun-Hwa
    Kim, Ye-Ji
    Seo, Jeong-Wook
    Kim, Kee K.
    Ka, Minhan
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2021, 428
  • [49] Electrospun Scaffolds and Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Cardiac Tissue Engineering Applications
    Suh, Taylor Cook
    Amanah, Alaowei Y.
    Gluck, Jessica M.
    BIOENGINEERING-BASEL, 2020, 7 (03): : 1 - 22
  • [50] Engineered human myocardium for enhanced maturation of pluripotent stem cell-derived cardiomyocytes
    Tiburcy, M.
    Liaw, N.
    Schlick, S.
    Zimmermann, W-H
    ACTA PHYSIOLOGICA, 2019, 227 : 17 - 17
12345